AAPL

TSLA

AMZN

META

AMD

NVDA

PEP

COST

ADBE

GOOG

AMGN

HON

INTC

INTU

NFLX

ADP

SBUX

MRNA

Markets

PHR

Why Phreesia Stock Flopped Today

March 31, 2026 — 11:00 am EDT

Written by

Rich Smith for

The Motley Fool->

Key Points

- Phreesia beat on sales but missed on earnings last night.

- Management also lowered guidance for sales growth this year, fiscal 2027.

- 10 stocks we like better than Phreesia ›

Phreesia (NYSE: PHR) stock collapsed on Tuesday, falling 27.5% through 10:20 a.m. ET after reporting mixed earnings results for its fiscal Q4 2026 last night.

Heading into the report, analysts expected the digital doctor's office front desk service to earn $0.06 per share on sales of $126.9 million in sales. Phreesia actually beat the revenue estimate, reporting $127.1 million, but it missed badly on earnings, reporting only $0.02 per share.

Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »

Image source: Getty Images.

Phreesia Q4 earnings

Not all the news was bad. Phreesia grew sales 16% year over year, and flipped to a Q4 profit -- and a full-year profit as well ($0.04 per share). Free cash flow was also positive, $28.5 million for the quarter and $54.4 million for the year (deducting both capital spending and capitalized software costs from operating cash flow, to arrive at FCF).

Even admitting the earnings miss, however, it wasn't really last year's results that tripped up Phreesia this morning. It was the guidance for next year.

What's next for Phreesia

Turning to fiscal 2027 guidance, Phreesia warned that it's losing "visibility" into spending commitments by "certain" pharmaceutical manufacturers. These customers might still spend as previously expected, but they are not "committing" to do so, making Phreesia less certain of its guidance numbers.

Phreesia is responding by giving more conservative revenue guidance for the coming fiscal year -- $510 million to $520 million, down from $545 million to $559 million previously. This is still 7% projected growth from fiscal 2026, but it's well below the $552 million that Wall Street has been expecting.

With Phreesia stock trading at roughly 26 times trailing FCF and growth now in the single digits, Phreesia stock appears to cost more than it's worth.

Should you buy stock in Phreesia right now?

Before you buy stock in Phreesia, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Phreesia wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $501,381!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,012,581!*

Now, it’s worth noting Stock Advisor’s total average return is 880% — a market-crushing outperformance compared to 178% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of March 31, 2026.

Rich Smith has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.